How should I manage a patient with five days of insomnia and a creatine kinase level of 3000 U/L?

Management of Insomnia with Elevated Creatine Kinase

Immediately investigate for drug-induced causes (particularly antipsychotics or serotonergic agents), check for serotonin syndrome or neuroleptic malignant syndrome, assess thyroid function, and ensure adequate hydration while monitoring renal function—this CK elevation (3000 U/L) with insomnia requires urgent evaluation for potentially life-threatening medication-related syndromes.

Initial Assessment and Risk Stratification

Determine if CK Elevation is Clinically Significant

• A CK of 3000 U/L represents approximately 3-10 times the upper limit of normal (depending on sex and ethnicity), which crosses the threshold requiring investigation 1.
• This level warrants immediate evaluation as it falls into the range where complications can occur, though it is below the threshold for severe rhabdomyolysis (typically >10,000-30,000 U/L) 1.

Urgent Differential Diagnosis to Rule Out

Medication-induced syndromes (highest priority given the insomnia presentation):

• Serotonin syndrome: If the patient is taking any serotonergic medications (SSRIs, SNRIs, triptans, tramadol, etc.), look for myoclonus, hyperreflexia, clonus, hyperthermia, agitation, and diaphoresis 1.

  • Myoclonus occurs in 57% of cases and clonus/hyperreflexia are highly diagnostic 1.
  • Severe cases present with CK elevation, metabolic acidosis, renal failure, and mortality of approximately 11% 1.

• Neuroleptic malignant syndrome (NMS): If on antipsychotics or dopamine antagonists, assess for rigidity, altered mental status, and autonomic instability 1.

  • Onset is typically over days (1-7 days) with elevated temperature and CK 1.

• Antipsychotic-induced CK elevation: Asymptomatic CK rises can occur with multiple antipsychotics 2.

Immediate Management Steps

Stop Potentially Causative Medications

• Discontinue any serotonergic agents, antipsychotics, or other medications that could cause myopathy 1.
• Avoid physical restraints if agitation is present, as they worsen isometric contractions and can exacerbate hyperthermia and lactic acidosis 1.

Assess for Rhabdomyolysis Risk

• Check renal function (creatinine, BUN), electrolytes (particularly potassium), urinalysis for myoglobinuria, and metabolic acidosis 1.
• At CK 3000 U/L, aggressive IV hydration is indicated to prevent acute kidney injury, though mannitol is only beneficial at markedly higher levels (>30,000 U/L) and is contraindicated in oligoanuria 1.
• Monitor for compartment syndrome risk factors if there is any history of trauma, crush injury, or prolonged immobilization 1.

Essential Laboratory Workup

• Thyroid function tests (TSH, free T4): Hypothyroidism can cause profound CK elevations (even >29,000 U/L) with minimal systemic symptoms 3.

  • Thyroid replacement resolves both weakness and CK elevation 3.

• Repeat CK measurement after 48 hours of rest to confirm persistence and trend 4, 5.

• Complete blood count, hepatic transaminases, coagulation studies to assess for systemic complications 1.

Addressing the Insomnia

First-Line Treatment

• Cognitive-behavioral therapy for insomnia (CBT-I) is the first-line treatment and should be initiated either in-person or digitally 1, 6, 7.
  • CBT-I improves global and sleep outcomes with moderate-strength evidence 1.
  • This avoids pharmacological agents that could be contributing to CK elevation 1, 6.

Pharmacological Considerations (Only After Ruling Out Drug-Induced Causes)

If CBT-I is insufficient and medication-induced causes are excluded:

• Short-term options (≤4 weeks): Benzodiazepine receptor agonists (zolpidem, eszopiclone), daridorexant, or low-dose sedating antidepressants 1, 6.
• Longer-term options: Orexin receptor antagonists (suvorexant) for up to 3 months or longer 6.
• For patients ≥55 years: Prolonged-release melatonin for up to 3 months 6.

Avoid: Antihistamines, antipsychotics (given CK elevation), and fast-release melatonin 6.

Monitoring Protocol

CK Monitoring Strategy

• If CK <4x ULN with symptoms: Continue monitoring while investigating cause 1.
• If CK ≥4x ULN but <10x ULN without symptoms: Continue monitoring CK closely 1.
• If CK ≥4x ULN with symptoms: Stop any potentially causative agents and monitor for normalization 1.
• If CK >10x ULN: Stop all potentially causative medications, check renal function, and monitor CK every 2 weeks 1.

Renal Function Monitoring

• Monitor creatinine and urine output given the risk of acute kidney injury at this CK level 1.
• Maintain adequate hydration with IV fluids if indicated 1.

Common Pitfalls to Avoid

• Do not assume the insomnia and CK elevation are unrelated—they may both be manifestations of a medication-induced syndrome 1, 2.
• Do not prescribe additional psychotropic medications without first ruling out drug-induced causes of CK elevation 1, 2.
• Do not delay thyroid testing—hypothyroidism can present with minimal systemic symptoms but profound CK elevation 3.
• Do not use diuretics to prevent AKI in rhabdomyolysis—they may worsen outcomes and are contraindicated in oligoanuria 1.
• Do not ignore the possibility of sleep deprivation itself affecting creatine metabolism, though this typically causes modest elevations 8.

When to Refer

• Refer to a neurologist or neuromuscular specialist if CK remains elevated after addressing reversible causes, particularly if CK is persistently ≥3x normal, EMG is myopathic, or the patient is <25 years old 5.
• Consider sleep medicine referral for refractory insomnia requiring specialized CBT-I or complex pharmacological management 1, 6.